Article
Cardiac & Cardiovascular Systems
Dritan Useini, Blerta Beluli, Hildegard Christ, Markus Schloemicher, Elias Ewais, Polykarpos Patsalis, Peter Haldenwang, Hamid Naraghi, Vadim Moustafine, Matthias Bechtel, Justus Strauch
Summary: The study aimed to evaluate the mid-term outcomes of patients with diverse aortic diseases undergoing transapical TAVI. Results showed that transapical TAVI is a safe and effective method, with reasonable median survival time and freedom from death and cardio-cerebral adverse events.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2021)
Article
Cardiac & Cardiovascular Systems
Sarah Yousef, James A. Brown, Derek Serna-Gallegos, Forozan Navid, Nav Warraich, Pyongsoo Yoon, David Kaczorowski, Johannes Bonatti, Yisi Wang, Ibrahim Sultan
Summary: This study compared outcomes of aortic valve replacement (AVR) with or without aortic root enlargement (ARE). It found that patients who underwent AVR+ARE were more likely to be women, younger, and had longer hospital stays, higher rates of acute kidney injury, blood transfusions, and prolonged ventilation. However, survival rates and complication rates were similar between the two groups. In conclusion, for patients with small aortic annulus, AVR+ARE can be safely performed to avoid prosthesis-patient mismatch.
ANNALS OF THORACIC SURGERY
(2023)
Article
Medicine, General & Internal
Do Jung Kim, Sak Lee, Hyun-Chel Joo, Young-Nam Youn, Kyung-Jong Yoo, Seung Hyun Lee
Summary: The study evaluated the hemodynamics and clinical outcomes of Trifecta and C-E bioprostheses in small aortic annuli, showing significantly lower transvalvular pressure gradient in the Trifecta group at discharge. However, hemodynamics over time and clinical outcomes did not differ between the two designs.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Yunxing Xue, Qing Zhou, Shuchun Li, Jie Li, Dan Mu, Xuan Luo, Chang Liu, Can Xu, Dongjin Wang
Summary: The J-Valve system is effective in treating patients with aortic valve diseases, with a high technical success rate and low complication rate. It offers advantages for high-risk patients and cases of pure aortic regurgitation.
ANNALS OF THORACIC SURGERY
(2021)
Article
Cardiac & Cardiovascular Systems
Peter Stachon, Klaus Kaier, Vera Oettinger, Wolfgang Bothe, Manfred Zehender, Christoph Bode, Constantin von zur Muehlen
Summary: Based on nationwide data in Germany, older patients with more comorbidities and higher operative risk may have lower in-hospital complications when undergoing transapical transcatheter aortic valve replacement (TA-TAVR) compared to surgical aortic valve replacement (SAVR). However, younger patients <75 years and those with lower operative risk scores of 4-9 may benefit more from SAVR than TA-TAVR.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
(2021)
Article
Veterinary Sciences
Florian Meissner, Michelle Costa Galbas, Johannes Dinkelaker, Heidi Cristina Schmitz, Hendrik Straky, Johanna Reuter, Martin Czerny, Wolfgang Bothe
Summary: This article reports on a rare case of an intra-aortic band in a German Landrace pig, which hindered the implantation of a left ventricular assist device during animal testing. The band was located at the sinotubular junction, and awareness of such anomalies is important for planning and performing animal testing. Preoperative echocardiography can help remove such anomalies.
BMC VETERINARY RESEARCH
(2023)
Article
Medicine, General & Internal
Daniela Geisler, Piotr Nikodem Rudzinski, Waseem Hasan, Martin Andreas, Ena Hasimbegovic, Christopher Adlbrecht, Bernhard Winkler, Gabriel Weiss, Andreas Strouhal, Georg Delle-Karth, Martin Grabenwoeger, Markus Mach
Summary: The study identified risk factors associated with higher one-year mortality following TF and TA TAVR, including cerebrovascular disease, home oxygen dependency, wheelchair dependency, periinterventional myocardial infarction, and postinterventional renal replacement therapy. It emphasizes the importance of precise preinterventional evaluation and highlights the subtle differences in baseline characteristics between the TF and TA cohorts and their impact on one-year mortality.
JOURNAL OF CLINICAL MEDICINE
(2021)
Editorial Material
Cardiac & Cardiovascular Systems
Gino Gerosa, Giorgia Cibin, Michele Antonello, Augusto D'Onofrio
Summary: An 84-year-old patient underwent a combined procedure including balloon aortic valvuloplasty, ascending aorta stent-graft implantation, and transapical transcatheter aortic valve replacement. The patient had a complication-free hospital stay, demonstrating the feasibility and safety of this approach in selected high-risk patients.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
(2021)
Article
Cardiac & Cardiovascular Systems
Minjian Kong, Ze Hong, Xianbao Liu, Xian Zhu, Jianan Wang, Aiqiang Dong
Summary: This study analyzed the short-term clinical outcomes of TA-TAVR compared with SAVR in symptomatic aortic regurgitation patients. It found that TA-TAVR is safe and reliable, with similar clinical efficacy to SAVR, and has advantages in bleeding rate and speed of recovery.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE
(2022)
Article
Cardiac & Cardiovascular Systems
Dritan Useini, Markus Schloemicher, Peter Haldenwang, Dirk Buchwald, Justus Strauch
Summary: This study aimed to evaluate the early and midterm outcomes after transapical-transcatheter aortic valve implantation (TA-TAVI) in patients with iliofemoral and concomitant iliofemoral-remote arteriopathies who cannot undergo transfemoral or other alternative transvascular approaches. The study included 72 consecutive elderly patients, and no procedural deaths or conversion to conventional surgery was registered. The 30-day and midterm mortality rates were 5% and 28%, respectively. TA-TAVI showed good early and midterm outcomes in patients with extensive panarteriopathy for whom transfemoral and other alternative transvascular approaches are contraindicated or at high interventional risk.
JOURNAL OF CARDIAC SURGERY
(2022)
Article
Cardiac & Cardiovascular Systems
Uri Landes, Guy Witberg, Janarthanan Sathananthan, Won-Keun Kim, Pablo Codner, Nicola Buzzatti, Matteo Montorfano, Rebecca Godfrey, David Hildick-Smith, Chiara Fraccaro, Giuseppe Tarantini, Ole De Backer, Lars Sondergaard, Taishi Okuno, Thomas Pilgrim, Josep Rodes-Cabau, Ronen Jaffe, Amnon Eitan, Jan-Malte Sinning, Alfonso Ielasi, Helene Eltchaninoff, Pal Maurovich-Horvat, Bela Merkely, Mayra Guerrero, Abdallah El Sabbagh, Philipp Ruile, Marco Barbanti, Simon R. Redwood, Nicolas M. Van Mieghem, Maarten P. H. Van Wiechen, Ariel Finkelstein, Matjaz Bunc, Martin B. Leon, Ran Kornowski, John G. Webb
Summary: The study examined the incidence, causes, and outcomes of 2-valve transcatheter aortic valve replacement (TAVR) and found that 2V-TAVR was associated with a higher risk of complications and mortality at 30 days compared to 1V-TAVR, but not at 1 year. Risk factors for 2V-TAVR included bicuspid or regurgitant aortic valve, nontransfemoral access, and early-generation or self-expandable valve.
Article
Cardiac & Cardiovascular Systems
Michael Dismorr, Natalie Glaser, Anders Franco-Cereceda, Ulrik Sartipy
Summary: Prosthesis-patient mismatch (PPM) is common after surgical aortic valve replacement (SAVR). Increasing grades of PPM are associated with long-term mortality and severe PPM is associated with increased heart failure. Moderate PPM is common, but the clinical significance may be negligible.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Review
Cardiac & Cardiovascular Systems
Douglas Leedy, David M. Elison, Francisco Farias, Richard Cheng, James M. McCabe
Summary: The prevalence of concurrent cancer and severe aortic stenosis (AS) is increasing due to an ageing population. Patients with cancer may be at increased risk for AS due to off-target effects of cancer-related therapy and shared non-traditional pathophysiological mechanisms. Transcatheter aortic valve intervention (TAVI) is a viable option for treating AS in cancer patients, with lower major adverse events especially in those with history of mediastinal radiation therapy. However, outcomes are dependent on cancer survival.
Article
Cardiac & Cardiovascular Systems
Nicolas M. Van Mieghem, G. Michael Deeb, Lars Sondergaard, Eberhard Grube, Stephan Windecker, Hemal Gada, Mubashir Mumtaz, Peter S. Olsen, John C. Heiser, William Merhi, Neal S. Kleiman, Stanley J. Chetcuti, Thomas G. Gleason, Joon Sup Lee, Wen Cheng, Raj R. Makkar, Juan Crestanello, Barry George, Isaac George, Susheel Kodali, Steven J. Yakubov, Patrick W. Serruys, Ruediger Lange, Nicolo Piazza, Mathew R. Williams, Jae K. Oh, David H. Adams, Shuzhen Li, Michael J. Reardon
Summary: Among intermediate-risk patients with symptomatic severe aortic stenosis, major clinical outcomes at 5 years were similar for TAVR and surgery. TAVR was associated with superior hemodynamic valve performance but also with more paravalvular leak and valve reinterventions.
Article
Medicine, General & Internal
Manuel Carnero-Alcazar, Emiliano Rodriguez-Caulo, Daniel Hernandez-Vaquero, Lourdes Montero-Cruces, Daniel Perez-Camargo, David Fernandez-De Velasco, Javier Cobiella-Carnicer, Luis Maroto-Castellanos
Summary: Between 2007 and 2018, there was a significant increase in the use of bioprostheses in patients undergoing SAVR in Spain, and a great variability in the types of valve between the Spanish territories, which was not explained by the different risk profiles of patients.
JOURNAL OF CLINICAL MEDICINE
(2021)
